MedTrace Logo

NORCCAP: Norwegian Colorectal Cancer Prevention Trial

NCT00119912 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100000

Last updated 2026-04-14

No results posted yet for this study

Summary

The purpose of this study is to see if screening with flexible sigmoidoscopy (a flexible viewing tube) may reduce large bowel cancer and cancer deaths. The researchers also want to see if the addition of screening for occult blood in stools may contribute further to this aim. Additionally, the researchers also want to see to which extent (and in which direction) the study may influence overall endoscopic activity in the general population in the screening area and in areas where controlled screening is not established.

Conditions

Interventions

PROCEDURE

A 1 Intervention arm Flex Sig

Screening by flexible sigmoidoscopy

PROCEDURE

A 2 Intervention arm Flex Sig + iFOBT

In addition to Flexible Sigmoidoscopy, half of arm A (randomised 1:1) is invited to provide stool samples for FOBT

Sponsors & Collaborators

  • Norwegian Cancer Society

    collaborator OTHER

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Principal Investigators

  • Giske Ursin, M.D. · Norwegian Institute of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1999-01-01
Primary Completion
2036-12-31
Completion
2036-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00119912 on ClinicalTrials.gov